Literature DB >> 26944009

Fecal microbiota transplantation for recurrent Clostridium difficile infection: The patient experience.

Amy L Pakyz1, Leticia R Moczygemba2, Lynn M VanderWielen3, Michael B Edmond4.   

Abstract

BACKGROUND: Although effectiveness of fecal microbiota transplantation (FMT) has been adequately documented, the patient experience of undergoing FMT has not.
METHODS: We carried out a qualitative interview study using semistructured questions relating to aspects of health pre-FMT, during FMT, and post-FMT periods with 17 participants. Inductive coding was used to identify core themes during the periods.
RESULTS: Pre-FMT themes included physical (continuous diarrhea and weight loss), mental (depression, wanting to die, and fear), quality of life (unable to perform normal activities), social support, and financial (medication costs) factors. Provider resistance/limited awareness were barriers to FMT. Participants reached a tipping point, experiencing feelings of hopelessness, which led them to pursue FMT. During FMT, participants commented on lack of a so-called ick factor. During the posttreatment period, participants experienced symptom relief, but had residual fears. Patient activation was present during all phases, including information seeking and empowerment.
CONCLUSIONS: During the pre-FMT period, participants experienced extreme discomfort and encountered FMT barriers. Undergoing FMT was reported as easy but residual fear remained. There were displays of patient activation at all FMT time periods, including the seeking of FMT. Participants could have benefited from having undergone FMT sooner, demonstrating a need for improvement in provider education and health system barriers regarding FMT.
Copyright © 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Qualitative study; fecal bacteriotherapy

Mesh:

Year:  2016        PMID: 26944009     DOI: 10.1016/j.ajic.2016.01.018

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  4 in total

1.  Physician and patient perceptions of fecal microbiota transplant for recurrent or refractory Clostridioides difficile in the first 6 years of a central stool bank.

Authors:  Madeleine Gill; Charlotte Blacketer; Franco Chitti; Karmen Telfer; Lito Papanicolas; Lisa M Dann; Emily C Tucker; Robert V Bryant; Samuel P Costello
Journal:  JGH Open       Date:  2020-08-06

2.  Experiences and perceptions of patients with psoriatic arthritis participating in a trial of faecal microbiota transplantation: a nested qualitative study.

Authors:  Maja Skov Kragsnaes; Shaun Theodor Sødergren; Jens Kjeldsen; Hans Christian Horn; Heidi Lausten Munk; Jens Kristian Pedersen; Camilla Schufri Klinkby; Maarten de Wit; Nanna Gram Ahlmark; Tine Tjørnhøj-Thomsen; Torkell Ellingsen
Journal:  BMJ Open       Date:  2021-03-08       Impact factor: 2.692

3.  The views of pregnant women in New Zealand on vaginal seeding: a mixed-methods study.

Authors:  Éadaoin M Butler; Abigail J Reynolds; José G B Derraik; Brooke C Wilson; Wayne S Cutfield; Celia P Grigg
Journal:  BMC Pregnancy Childbirth       Date:  2021-01-12       Impact factor: 3.007

4.  How Chinese clinicians face ethical and social challenges in fecal microbiota transplantation: a questionnaire study.

Authors:  Yonghui Ma; Jinqiu Yang; Bota Cui; Hongzhi Xu; Chuanxing Xiao; Faming Zhang
Journal:  BMC Med Ethics       Date:  2017-05-31       Impact factor: 2.652

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.